Arvinas Inc. (ARVN)
NASDAQ: ARVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 7.38 -0.94%
ARVN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $480.68M
- P/E (TTM)
- 28.65
- EPS (TTM)
- $0.26
- Dividend yield
- None
- 52-week range
- 6.97 – 14.51
- Day range
- 7.22 – 7.46
- Volume / Avg
- 601.59K / 779.91K
- Beta
- —
- Shares outstanding
- 64.52M
- Next earnings
- Nov 4, 2026
52-week range
ARVN stock today
Arvinas (ARVN) closed at $7.45 on Oct 7, up 1.92% (+$0.14), versus the S&P 500's 0.22% decline. Shares are 48.7% below their 52-week high of $14.51, set on Mar 10, 2026 and 6.9% above the 52-week low of $6.97, near the bottom of the past year's range. ARVN is down 37.2% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 19.9%.
At 28.7x trailing earnings, Arvinas trades above the peer-group median of 20.8x. Arvinas's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Arvinas
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2018
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-0.80
Arvinas peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CTNMContineum Therapeutics Inc. Class A | 12.73 | +0.63% | $478.92M | vs ARVN |
| CAPRCapricor Therapeutics Inc. | 8.10 | +4.52% | $470.93M | vs ARVN |
| ASMBAssembly Biosciences Inc. | 22.95 | +3.47% | $467.28M | vs ARVN |
| OVIDOvid Therapeutics Inc. | 2.36 | -0.42% | $460.90M | vs ARVN |
| ACRSAclaris Therapeutics Inc. | 3.40 | -8.11% | $500.48M | vs ARVN |
| KMDAKamada Ltd. | 7.89 | -2.71% | $455.33M | vs ARVN |
| CBIOCrescent Biopharma Inc. | 13.49 | -0.59% | $501.11M | vs ARVN |
| PBYIPuma Biotechnology Inc | 9.81 | +3.26% | $506.39M | vs ARVN |
Indexes, lists and sector
Arvinas stock FAQ
What is Arvinas's stock price today?
ARVN last traded at $7.45 as of Oct 7, 4:00 PM EDT, up 1.92% on the day. Prices are delayed at least 15 minutes.
When is Arvinas's next earnings date?
Arvinas is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-0.80.
What is ARVN's P/E ratio?
ARVN trades at a trailing P/E ratio of 28.65, compared with a median of 20.8 for its closest peers.
What is the ARVN 52-week high?
The 52-week high for ARVN is $14.51 and the 52-week low is $6.97. The stock is currently 48.7% below its high.